The Botswana Medicines Regulatory Authority (BoMRA) has recalled one batch of Flumed Syrup, a registered combination cough and cold preparation manufactured by Varichem Pharmaceuticals (Pvt) Ltd of Zimbabwe, after crystallisation was observed in the affected product.
Pharmacies, health facilities and other points of sale should identify and quarantine the batch below and handle returns under the supplier’s instructions. Crystallisation in an oral liquid means active ingredient has come out of solution, so the amount delivered in a 5ml dose can no longer be assumed to match the label — a material concern in a product whose paracetamol content is at a paediatric strength. Members of the public holding the batch are told to stop using it immediately and return it to the pharmacy, health facility or point of purchase where it was obtained.
| Product | Batch | Pack | Manufactured | Expiry |
|---|---|---|---|---|
| Flumed syrup (paracetamol 120mg, phenylephrine HCl 2.5mg, dextromethorphan HBr 2.0mg, chlorpheniramine maleate 0.5mg per 5ml) | 260180 | 100ml | 03/2026 | 02/28 |
The batch was manufactured in March 2026 and carries a February 2028 expiry, meaning the defect appeared within roughly five months of manufacture and well inside shelf life.
Source: Botswana Medicines Regulatory Authority public alert, https://www.linkedin.com/posts/botswana-medicines-regulatory-authority-bomra-24587a180_bomra-recall-of-flumed-syrup-batch-260180-share-7495766924044378114-3Z7E?utm_source=social_share_send&utm_medium=android_app&rcm=ACoAAAgqiKsBVtXrECmKDVturES4Knpfga2NtKA&utm_campaign=whatsapp
